New PKD Cures Act Could Help Millions With Kidney Disease

When Brea Battaglia woke up with severe pain at 15 years old, she had no idea her life was about to change forever. A CT scan revealed she had polycystic kidney disease, the same condition that affected her dad, uncle, grandpa, and great-grandpa.

Polycystic kidney disease causes cysts to grow in the kidneys, gradually enlarging them and destroying their ability to function. Over time, patients develop high blood pressure, severe abdominal pain, and eventually kidney failure.

The disease affects roughly 800,000 Americans and accounts for 10% of all dialysis patients under 65. Because it follows a dominant inheritance pattern, each child of an affected parent has a 50% chance of inheriting the condition.

Last week, Congress introduced the PKD Cures Act, legislation that could transform the landscape for families like Battaglia's. The bill would require the National Institutes of Health to expand and intensify research into treatments and potential cures for the disease.

Dr. Arlene Chapman runs a PKD Center of Excellence at the University of Chicago Medicine, where she treats over 2,000 patients from 800 families. She calls the legislation "a beautiful step forward" that could lead to increased funding and breakthrough discoveries.

Right now, the PKD Foundation is the only organization funding this research in the United States. Opening the door to federal investment could multiply the resources available to scientists searching for answers.

The Ripple Effect

The impact of this legislation extends far beyond American borders. Millions of people worldwide live with polycystic kidney disease, watching their kidney function decline while hoping for better options.

For families who've watched generation after generation struggle with the same painful condition, federal research investment represents more than policy. It represents the possibility that their children or grandchildren might be the first generation to escape the cycle.

The bill doesn't yet specify exact funding amounts, but Chapman hopes a working group will determine appropriate dollar figures to make real progress possible. Even without final numbers, the commitment to prioritize PKD research sends a powerful message to patients and researchers alike.

Battaglia remains optimistic about what expanded research could mean. "If we open this up into Congress and get more research, that gives more hope for the future to all of our community," she said.

For the first time in generations, families affected by polycystic kidney disease have reason to believe a cure might arrive in their lifetime.